These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28232266)

  • 1. Improving the dissolution rate of hydrophobic drugs through encapsulation in porous lactose as a new biocompatible porous carrier.
    Ebrahimi A; Saffari M; Langrish T
    Int J Pharm; 2017 Apr; 521(1-2):204-213. PubMed ID: 28232266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of acetaminophen as an active pharmaceutical ingredient into porous lactose.
    Ebrahimi A; Saffari M; Dehghani F; Langrish T
    Int J Pharm; 2016 Feb; 499(1-2):217-227. PubMed ID: 26768724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol.
    Saffari M; Ebrahimi A; Langrish T
    Eur J Pharm Sci; 2016 Feb; 83():52-61. PubMed ID: 26687442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.
    Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S
    Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
    Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
    Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
    Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate microparticles prepared by spray-coagulation method: preparation, drug loading and release characterization.
    Tu J; Bolla S; Barr J; Miedema J; Li X; Jasti B
    Int J Pharm; 2005 Oct; 303(1-2):171-81. PubMed ID: 16129575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.
    Planinšek O; Kovačič B; Vrečer F
    Int J Pharm; 2011 Mar; 406(1-2):41-8. PubMed ID: 21219991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
    Tay T; Allahham A; Morton DA; Stewart PJ
    J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
    Mehanna MM; Motawaa AM; Samaha MW
    J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution of ibuprofen from spray dried and spray chilled particles.
    Elkordy AA; Essa EA
    Pak J Pharm Sci; 2010 Jul; 23(3):284-90. PubMed ID: 20566441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents.
    Madieh S; Simone M; Wilson W; Mehra D; Augsburger L
    J Pharm Sci; 2007 Apr; 96(4):851-63. PubMed ID: 17221849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a dense gas solvent exchange process for the impregnation of pharmaceuticals into porous chitosan.
    Ji C; Barrett A; Poole-Warren LA; Foster NR; Dehghani F
    Int J Pharm; 2010 May; 391(1-2):187-96. PubMed ID: 20214968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.